BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25868960)

  • 21. [Hypertensive emergency and urgence].
    Gegenhuber A; Lenz K
    Herz; 2003 Dec; 28(8):717-24. PubMed ID: 14689106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between grade II hypertensive retinopathy and coronary artery disease in treated essential hypertensives.
    Kim GH; Youn HJ; Kang S; Choi YS; Moon JI
    Clin Exp Hypertens; 2010; 32(7):469-73. PubMed ID: 21029012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.
    Cremer A; Amraoui F; Lip GY; Morales E; Rubin S; Segura J; Van den Born BJ; Gosse P
    J Hum Hypertens; 2016 Aug; 30(8):463-6. PubMed ID: 26582411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The cardiovascular risk after renal transplantation (1): Hypertension and left ventricular hypertrophy].
    Covic A; Gusbeth-Tatomir P; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):651-6. PubMed ID: 12092214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral central retinal vein occlusion caused by malignant hypertension in a young patient.
    Balogh Z; Berta A; Pfliegler G; Nagy V
    Clin Exp Hypertens; 2011; 33(1):53-5. PubMed ID: 21166599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe and prolonged renal insufficiency. Reversal in a patient with malignant hypertension.
    Bacon BR; Ricanati ES
    JAMA; 1978 Mar; 239(12):1159-60. PubMed ID: 628071
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Accelerated arterial hypertension in a young male].
    Soler MJ; Parrilla J; Vázquez González S; Orfila A; Lloveras J
    Nefrologia; 2004; 24 Suppl 3():81-4. PubMed ID: 15219076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation.
    Ibernon M; Moreso F; Ruiz-Majoral A; Sarrias X; Sarrias M; Grinyó JM; Serón D
    Transplant Proc; 2011; 43(6):2199-204. PubMed ID: 21839233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal Imaging of Elschnig Spots: A Case of Simultaneous Hypertensive Retinopathy, Choroidopathy, and Neuropathy.
    Stryjewski TP; Papakostas TD; Eliott D
    Semin Ophthalmol; 2017; 32(4):397-399. PubMed ID: 27082847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant hypertension: does this still exist?
    Domek M; Gumprecht J; Lip GYH; Shantsila A
    J Hum Hypertens; 2020 Jan; 34(1):1-4. PubMed ID: 31636349
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant hypertension: new aspects of an old clinical entity.
    Januszewicz A; Guzik T; Prejbisz A; Mikołajczyk T; Osmenda G; Januszewicz W
    Pol Arch Med Wewn; 2016; 126(1-2):86-93. PubMed ID: 26658350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How does hypertension affect your eyes?
    Bhargava M; Ikram MK; Wong TY
    J Hum Hypertens; 2012 Feb; 26(2):71-83. PubMed ID: 21509040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
    Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients.
    Matteucci MC; Giordano U; Calzolari A; Turchetta A; Santilli A; Rizzoni G
    Kidney Int; 1999 Oct; 56(4):1566-70. PubMed ID: 10504509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
    Tomilina NA; Gendlin GE; Zhidkova DA; Tronina OA; Fedorova ND
    Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.